Argerich Josep, Muñoz-Reyes Daniel, Val-García Iris Del, García-Nafría Javier
Institute for Biocomputation and Physics of Complex Systems (BIFI) and Laboratorio de Microscopías Avanzadas (LMA), University of Zaragoza, Zaragoza, Spain.
Institute for Biocomputation and Physics of Complex Systems (BIFI) and Laboratorio de Microscopías Avanzadas (LMA), University of Zaragoza, Zaragoza, Spain.
J Biol Chem. 2025 Sep;301(9):110571. doi: 10.1016/j.jbc.2025.110571. Epub 2025 Aug 8.
G protein-coupled receptors (GPCRs) are a therapeutically privileged family of receptors involved in a wide variety of pathophysiological conditions and the successful target for ∼34% of FDA-approved drugs. However, a significant percentage of GPCRs remain orphan, i.e., the endogenous ligands that modulate receptor function are unknown, and hence knowledge about their functional role and the generation of new therapeutics lag behind. During recent years, the use of cryo-electron microscopy has revolutionized GPCR structural biology including its application to orphan GPCRs, especially those displaying constitutive activity in cellular model systems. Such efforts have resulted in the description of new modes of in-built agonists that include the ECL2 and N-terminal regions as well as identifying ubiquitous endogenous ligands readily bound to GPCRs. These results position structural determination as a new key component in GPCR deorphanization, shedding light on new signaling mechanisms, bringing questions about their functional regulation, and opening new avenues for drug design.
G蛋白偶联受体(GPCRs)是一类在治疗上具有重要地位的受体家族,参与多种病理生理状况,并且是约34%的FDA批准药物的成功靶点。然而,相当一部分GPCRs仍然是孤儿受体,即调节受体功能的内源性配体尚不清楚,因此关于它们的功能作用以及新疗法的开发滞后。近年来,冷冻电子显微镜的应用彻底改变了GPCR结构生物学,包括其在孤儿GPCRs中的应用,特别是那些在细胞模型系统中显示组成性活性的孤儿GPCRs。这些努力已经促成了对新的内源性激动剂模式的描述,这些模式包括胞外环2(ECL2)和N端区域,以及鉴定出容易与GPCRs结合的普遍存在的内源性配体。这些结果将结构测定定位为GPCR去孤儿化的一个新的关键组成部分,揭示了新的信号传导机制,引发了关于其功能调节的问题,并为药物设计开辟了新途径。